Blyth is the founder and former CEO of LIfT BioSciences, a company developing neutrophil-based immunotherapies designed to ...
PITTSBURGH, PA, UNITED STATES, February 27, 2026 /EINPresswire.com/ -- Tamara K. of Deer Lodge, TN is the creator of ...
Human spinal cord organoids have been used to model different types of spinal cord injuries and test a promising new regenerative therapy.
Merck , known as MSD outside of the United States and Canada, today announced the presentation of results from three pivotal Phase 3 trials evaluating the investigational, once-daily, oral, two-drug ...
When Katharine Burr Blodgett discovered nonreflecting glass, the General Electric Company’s public relations machine made her a star ...
Gemma Biotherapeutics ("GEMMABio"), a clinical?stage global genetic medicines company, announced today that the first patient has been dosed in the Phase 1/2 CHARISMA clinical trial of GB221, an ...
Researchers identified a molecular pathway that can limit muscle repair, a finding that may guide future muscular dystrophy treatments.
Blood vessel damage in the spinal cord may play a role in nerve cell loss in spinal muscular atrophy, a new study suggests.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results